Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.
NCT06139991
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Heathy Participants
Interventions
DRUG:
Treatment A (BDA MDI HFO)
DRUG:
Treatment B (BDA MDI HFA)
Sponsor
AstraZeneca